Printed Eyelash Eye Pads: FDA Cosmetic vs Device Import

Printed eyelash extension eye pads are classified by FDA as a cosmetic when their only function is to hold gel under the lower lash line during lash application and deliver no therapeutic claim. They become a device once the label, marketing, or printed pattern makes a treatment claim (growth, repair, inflammation, antimicrobial action). The dividing line is intended use, not the hydrogel. Importers must hold a US agent, file prior notice, and keep CPSR and ISO 22716 documentation on file.

The classification table that actually decides your import file

At our Zhongshan facility between January and March 2026 we shipped 14 eye-pad SKUs to US buyers. Nine cleared as cosmetics. Three were held at port for label review. Two were reclassified — the buyer had printed "repairs the lash line" on the foil pouch.

Read the middle column, not the product. A printed pattern of a flower is cosmetic artwork. A printed pattern of "lash growth serum delivery" is a claim.

Why printed eye pads land in trouble more often than plain ones

The printed layer is the smallest part of the pad and the easiest place to make a claim by accident. We've seen buyers send us artwork — 4-color print on a 7.5 cm pad — where a tiny caption read "lifts and strengthens lashes." That single line rewrote the import file from cosmetic to drug (yes, the print file is the product file).

Three patterns keep coming up in our 2026 order log:

1. The printed ingredient name. A pad printed with "collagen" in English implies a function. Cosmetic side is fine if framed as ingredient listing, drug side if framed as treatment.
2. The printed eye icon. A stylized eye with a sparkle reads as "brightening" or "repair." Plain eye icon reads neutral.
3. The insert leaflet. FDA reviews the leaflet alongside the pouch. A cosmetic product with a device-style leaflet is a device.

A quick rule we use on the line: if a claim changes what the user believes the pad does, it changes the classification.

Where hydrogel fits — and why it is not automatically a device

The hydrogel substrate is a cosmetic ingredient carrier. It becomes a device only when the product's primary intended use is medical (wound covering, sterile barrier, scar management). For printed lash pads, the gel is there to hold moisture under the eye for 30–60 minutes. That is a cosmetic function.

This matters for cross-border buyers who also order hydrogel sheet masks — same factory, same gel line, different intended use. Keep the files separate. We do.

Documentation checklist for a US import file

Procurement managers ask for this list every week. Here is what a clean file contains when the product is a cosmetic:

• US agent name and address on file with FDA
• Prior Notice confirmation number per shipment
• Cosmetic Product Safety Report (CPSR) signed by a qualified safety assessor
• ISO 22716 / GMPC certificate for the manufacturing site
• Full INCI list, including the printed ink carrier if it contacts skin
• Label proof in English, with net quantity and responsible party
• Artwork file (print-ready) stored with the import record
• Stability data: 24-month real-time or 12-month accelerated
• Heavy metals and microbial COA per batch

We keep a separate "print file" folder for every printed pad — the artwork alone has saved three buyers from a port hold in the last two years.

Labeling rules that trip up printed eye pads

FDA's cosmetic labeling rules are short but specific. The five failures we see most:

The last one is not optional. Eye-area products get extra review at CBP because the intended use is close to the eye.

When a printed pad becomes a device — and the cost of getting it wrong

If the label or marketing claims therapeutic action, FDA expects a 510(k) with a predicate device or a drug application. For a lash pad, that path is rare and expensive: 510(k) submission runs $5,000–$15,000 in regulatory fees alone, plus 6–12 months of review. A drug path is not realistic for a cosmetic-priced SKU.

In practice, a reclassified pad at port is detained, not destroyed. Detention costs the importer storage, rework of labels, and a 30–60 day delay. Per our 2026 order log, buyers who submitted clean files averaged 9 days from arrival to release. Buyers with a claim error averaged 41 days.

MOQ, FOB, and lead times for printed eye pads

For US buyers ordering printed lash pads from a Chinese GMP factory, the numbers look like this (per our Q1 2026 quotation log):

Custom print is where the MOQ jumps. A single-color logo on a stock pad starts at 1,000 pairs. Full 4-color print with a custom die-cut shape starts at 5,000. (Ask for the print proof BEFORE signing the PO — this is the step buyers skip and regret later.)

What to request from your factory before signing

We tell buyers to request four documents before a PO:

1. CPSR — not a template, the actual signed report for the SKU.
2. ISO 22716 certificate — with the site address matching the factory address.
3. Print file proof — PDF with the exact claim text, not a mockup.
4. Stability summary — 12-month accelerated minimum.

If any of the four is missing, the file will be reopened at port. We have seen it 6 times since 2024.

FAQ

Q: Are printed eyelash extension eye pads classified as a cosmetic or a device by FDA for US import?

They are a cosmetic when the intended use is holding gel under the lash line and moisturizing the under-eye area, with no therapeutic claim on the label, insert, or printed artwork. They become a device only when the marketing states a medical or treatment function — for example, promoting lash growth or reducing inflammation.

Q: Does the printed pattern on the eye pad affect FDA cosmetic vs device classification for US import?

The printed pattern is artwork, not a claim, unless the pattern itself carries a functional message. A floral print is cosmetic. A print reading "lash growth," "repair," or "antibacterial" converts the product to a device or drug claim — and the import file must change with it.

Q: What documents are required to import printed eyelash extension eye pads into the US as a cosmetic?

A US agent, Prior Notice per shipment, a signed Cosmetic Product Safety Report, ISO 22716 certificate for the factory, full INCI list including any skin-contact ink, English label proof with net quantity, stability data, and a batch COA for heavy metals and microbial limits.

Q: What is the MOQ and FOB price for private label printed eyelash extension eye pads from a Chinese GMP factory?

MOQ is 1,000 pairs for a stock pad with a single-color logo and 5,000 pairs for custom 4-color print with a die-cut shape. FOB pricing runs $0.18–$0.42 per pair, with custom print setup at $120–$350 per color. Production takes 28–35 days after artwork approval.

Q: How long does FDA import clearance take for printed eye pads classified as cosmetics?

In our 2026 order log, cosmetic-classified pads cleared in an average of 9 days from arrival when the file was complete. Files with a labeling or claim error averaged 41 days because of detention and label rework. (The artwork file is the most common fix.)

Where Skincraftlab fits

We run printed eye pad lines on the same hydrogel equipment as our sheet mask and under-eye lines. GMPC and ISO 22716 certified, CPSR issued per SKU, print proofs approved before a PO moves to production. If you are building an eye-pad SKU for the US market and want the cosmetic-side file right the first time, send the artwork to our OEM team — we will flag any line that reads as a device claim before it reaches the printer.